Korea South
IVIM Technology, founded in 2017, positions itself as a pioneering player in the realm of intraVital Microscopy, offering solutions that push the boundaries of conventional imaging technologies. Operating out of South Korea, the company has developed the world's first All-in-One microscopy (IVM) platform designed to transform the analysis of cellular interactions within living organisms. This technology surpasses traditional modalities like MRI or CT by enabling real-time, three-dimensional tracking of live cells, thus providing an invaluable tool for the Biopharma, Biotechnology, and Life Sciences industries.
IVIM Technology has successfully secured a KRW15.00B Series C investment as of April 21, 2022, backed by a formidable roster of investors including LB Investment, Mirae Asset Venture Investment, Premier Partners, BNH Investment, Timepolio Asset Management, and Atinum Partners. Their capital input is a testament to the company's potential to redefine disease analysis and the in vivo testing of biopharmaceuticals. With this innovative edge, IVIM Technology is positioned as a formidable contender in high-tech imaging.
